Spots Global Cancer Trial Database for IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Official Title: IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Study ID: NCT01931865
Conditions
Interventions
Study Description
Brief Summary: The purpose of this research study is to investigate the safety and effectiveness of botulinum toxin A (Xeomin) ® injections in patients who suffer from focal pain in areas of radiation and/or surgery as a result of cancer treatment. Our hypothesis is that injection of incobotulinum toxin A into an area of local pain, at or around the area of a post-surgical/post radiation scar, relieves the focal cancer pain.
Detailed Description: Please contact the PI for more detailed information.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Yale Physician Building, New Haven, Connecticut, United States
Contact Details
Name: Bahman Jabbari, MD
Affiliation: Yale School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
